The Role of OX40-Mediated Co-stimulation in T-Cell Activation and Survival
- 1 January 2009
- journal article
- review article
- Published by Begell House in Critical Reviews in Immunology
- Vol. 29 (3), 187-201
- https://doi.org/10.1615/critrevimmunol.v29.i3.10
Abstract
The extent of T-cell activation, proliferation, and survival that follows T-cell receptor (TCR) ligation is controlled by several factors, including the strength of TCR stimulation, the availability of prosurvival cytokines, and the presence or absence of co-stimulatory signals. In addition to engagement of the CD28 co-stimulatory receptor by its natural ligands, B7.1 (CD80) and B7.2 (CD86), recent work has begun to elucidate the mechanisms by which signaling through the OX40 (CD134) co-stimulatory receptor, a member of the tumor necrosis factor receptor (TNFR) superfamily, affects T-cell responses. Importantly, OX40 ligation has been shown to augment CD4 and CD8 T-cell clonal expansion, effector differentiation, survival, and in some cases, abrogate the suppressive activity of regulatory FoxP3+CD25+CD4+ T cells. In this review, we focus on the mechanisms regulating OX40 expression on activated T cells as well as the role of OX40-mediated co-stimulation in boosting T-cell clonal expansion, effector differentiation, and survival.Keywords
This publication has 99 references indexed in Scilit:
- Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cellsBlood, 2008
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejectionThe Journal of Experimental Medicine, 2008
- In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammationJournal of Clinical Investigation, 2007
- OX40 costimulation turns off Foxp3+ TregsBlood, 2007
- Anti‐OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responsesEuropean Journal of Immunology, 2006
- Anti-OX40 (CD134) Administration to Nonhuman Primates: Immunostimulatory Effects and Toxicokinetic StudyJournal of Immunotherapy, 2006
- Sustained Survivin Expression from OX40 Costimulatory Signals Drives T Cell Clonal ExpansionImmunity, 2005
- Functional expression of CD134 by neutrophilsEuropean Journal of Immunology, 2004
- OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in miceEuropean Journal of Immunology, 2003
- Both Amino- and Carboxyl-Terminal Domains of TRAF3 Negatively Regulate NF-κB Activation Induced by OX40 SignalingBiochemical and Biophysical Research Communications, 2000